Roche for Early Stage Alzheimer's Disease
- 60-80 years old
- Pre-symptomatic and at risk for developing Alzheimer's Disease
Okanagan Clinical Trials is inviting individuals that are pre-symptomatic and at risk for developing Alzheimer’s disease to take part in a new research study of an investigational treatment for this indication.
Men and women between the ages of 60 to 80 years, who are not experiencing any memory or thought-processing problems, may be eligible to participate. All study-related care and investigational treatment will be provided at no cost, and you may be compensated for your time and travel.